Pure Global

VIASURE Pathogen Extraction Kit for VIASURE V-Flex, 96 reactions - Vietnam Registration 240002350/PCBA-HN

Access comprehensive regulatory information for VIASURE Pathogen Extraction Kit for VIASURE V-Flex, 96 reactions in Vietnam's medical device market through Pure Global AI's free database. This Risk Class TBYT Loại A medical device is registered under number 240002350/PCBA-HN and manufactured by CERTEST BIOTEC, S.L.. The authorized representative in Vietnam is CÔNG TY TNHH THIẾT BỊ KHOA HỌC VIỆT ANH.

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 300,000+ Vietnamese medical device registrations, helping global MedTech companies navigate Vietnam MOH regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
300,000+ Devices
240002350/PCBA-HN
Registration Details
Vietnam MOH Registration: 240002350/PCBA-HN
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Device Details

VIASURE Pathogen Extraction Kit for VIASURE V-Flex, 96 reactions
VN: Bộ tách chiết mầm bệnh từ mẫu máu VIASURE cho VIASURE V-Flex, 96 phản ứng
Risk Class TBYT Loại A

Registration Details

240002350/PCBA-HN

000.00.19.H26-241021-0004

VIASURE Blood Pathogens Extraction Kit for VIASURE V-Flex, 96 prep

VS-EAB0196FX

Company Information

SPAIN

Certest Biotec, S.L

Technical Details

Designed to separate and purify the DNA and RNA of viruses, bacteria, and parasites from different clinical samples (whole blood, serum, plasma, blood culture, cerebrospinal fluid, bronchoalveolar lavage, and fresh urine) for subsequent diagnostic purposes using the VIASURE V-Flex automated extraction system. The product contains different reagents to process clinical samples in the automated platform and facilitates the detection of pathogens with real-time PCR (qPCR and RT-qPCR). This product is not intended for diagnostic, preventive, or therapeutic purposes.

Dates and Status

Oct 24, 2024